Angiomax RTU
- Product NDC
- 70511-141
- 11-digit product format
- 705110141
- Labeler code
- 70511
- Product ID
- 70511-141_c8f326c4-cccd-4985-b1ee-54db1bc52d50
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bivalirudin
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- MAIA Pharmaceuticals, Inc.
- Application
- NDA211215
- Marketing category
- NDA
- Marketing start
- 2019-08-08
- Marketing end
- 0000-00-00
- Substance
- BIVALIRUDIN
- Active strength
- 250 mg/1
- Pharmacologic classes
- Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70511-141-50 | 70511014150 | 1 INJECTION, SOLUTION in 1 CARTON (70511-141-50) | 2019-08-08 | 0000-00-00 | No | No | Current | |
| 70511-141-84 | 70511014184 | 1 VIAL in 1 PACKAGE (70511-141-84) > 10 INJECTION, SOLUTION in 1 VIAL | 1 vial | 2019-08-08 | 0000-00-00 | No | No | Current |